Tag: GCP compliance

Missing Data Challenges in DCT, ePRO and App-Based Trial Designs

Posted on By digi

Missing Data Challenges in DCT, ePRO and App-Based Trial Designs Missing Data Challenges in DCT, ePRO and App-Based Trial Designs In the rapidly evolving landscape of clinical research, the emergence of decentralized clinical trials (DCT), electronic patient-reported outcomes (ePRO), and app-based trial designs has significantly transformed how data is collected and managed. However, these innovations…

Read More “Missing Data Challenges in DCT, ePRO and App-Based Trial Designs” »

Missing Data Strategies & Sensitivity Analyses

Incorporating RBM into Risk Management Plans and DSURs

Posted on By digi

Incorporating RBM into Risk Management Plans and DSURs In the evolving landscape of clinical research, the adoption of Risk-Based Monitoring (RBM) frameworks has become crucial, particularly in the context of ensuring comprehensive risk management. This tutorial provides clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU with a step-by-step guide…

Read More “Incorporating RBM into Risk Management Plans and DSURs” »

Documentation for Regulators

Checklists for RBM Documentation Before Major Health Authority Meetings

Posted on By digi

Checklists for RBM Documentation Before Major Health Authority Meetings Checklists for RBM Documentation Before Major Health Authority Meetings Introduction to Risk-Based Monitoring (RBM) in Clinical Trials Risk-Based Monitoring (RBM) is a strategic approach utilized during the conduct of clinical trials, particularly in phase 3b clinical trials. This method emphasizes the prioritization of critical data for…

Read More “Checklists for RBM Documentation Before Major Health Authority Meetings” »

Documentation for Regulators

Cloud and API Strategies for Near Real-Time Clinical Data Integration

Posted on By digi

Cloud and API Strategies for Near Real-Time Clinical Data Integration Cloud and API Strategies for Near Real-Time Clinical Data Integration The advancement of technology has greatly transformed the landscape of clinical trials, bringing with it novel approaches for managing data. A critical aspect of this transformation is the integration of cloud and API strategies aimed…

Read More “Cloud and API Strategies for Near Real-Time Clinical Data Integration” »

Data Migration & Integration

Vendor and Partner Roles in Migration Planning and Execution

Posted on By digi

Vendor and Partner Roles in Migration Planning and Execution Vendor and Partner Roles in Migration Planning and Execution Introduction to Migration Planning in Clinical Trials As clinical trials evolve, the landscape of data management and integration becomes increasingly complex. The future of clinical trials hinges on effective collaboration between various stakeholders, including vendors and partners….

Read More “Vendor and Partner Roles in Migration Planning and Execution” »

Data Migration & Integration

Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data

Posted on By digi

Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data in Precision Medicine Clinical Trials In clinical trials, the management of missing data is a critical aspect that demands meticulous planning and execution. This article aims to provide a step-by-step tutorial designed for clinical operations, regulatory affairs, and medical…

Read More “Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data” »

Missing Data Strategies & Sensitivity Analyses

Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK

Posted on By digi

Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK In the realm of clinical research, the integration of a Risk-Based Monitoring (RBM) approach has been increasingly emphasized by regulatory authorities such as the FDA, EMA, and MHRA. This article aims to provide a comprehensive overview of the regulatory feedback on RBM submissions…

Read More “Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK” »

Documentation for Regulators

Balancing Transparency and Flexibility in RBM Documentation

Posted on By digi

Balancing Transparency and Flexibility in RBM Documentation Balancing Transparency and Flexibility in RBM Documentation The integration of Risk-Based Monitoring (RBM) in clinical trials has revolutionized the way data is collected, analyzed, and utilized throughout the clinical research process. This transition towards a more risk-based approach raises several documentation-related challenges that must be effectively addressed to…

Read More “Balancing Transparency and Flexibility in RBM Documentation” »

Documentation for Regulators

Using Standards to Simplify Integration Across Multiple Platforms

Posted on By digi

Using Standards to Simplify Integration Across Multiple Platforms Using Standards to Simplify Integration Across Multiple Platforms Introduction to Integration Standards in Clinical Trials The successful execution of clinical trials, including centerwatch clinical trials, relies heavily upon the effective integration of various data management platforms. In a landscape increasingly characterized by data heterogeneity and complexity, the…

Read More “Using Standards to Simplify Integration Across Multiple Platforms” »

Data Migration & Integration

Case Studies: Migration Failures and Lessons Learned for Future Programs

Posted on By digi

Case Studies: Migration Failures and Lessons Learned for Future Programs Data migration in clinical research is a critical aspect that ensures data integrity and compliance with regulatory standards. As clinical trials evolve, understanding migration pitfalls can lead to better management strategies. This article will provide a comprehensive overview of migration failures in clinical trials, incorporating…

Read More “Case Studies: Migration Failures and Lessons Learned for Future Programs” »

Data Migration & Integration